Key facts
- It has raised $14.1M; the latest was Later Stage VC in Jun 2025.
- Notable investors include TopoScend Capital, Huizhou Dayawan Petrochemical Industrial Park Investment, Realharmony Capital, Winzac Capital.
- Status: Privately Held (backing).
- ·The complete investor list — 4 names
- ·Watchlist + deal alerts for Raffles PharmaTech
- ·The full record, as it builds
Funding rounds
No funding rounds for Raffles PharmaTech are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Raffles PharmaTech
Developer of value added active pharmaceutical ingredients and intermediates intended to support development of new pharmaceuticals. The company is a tech enterprise that focuses on development, manufacturing and sales of value added active pharmaceutical ingredients, intermediates, and small molecule process development and manufacturing services, enabling pharmaceuticals and chemical industries to ensures precision, reliability, and efficiency in every stage of chemical development and production.
- Sector
- Healthcare
- HQ
- Huizhou, China
- Founded
- 2011
- Employees
- 200
- Website
- rafflespt.com/
- Ownership
- Privately Held (backing)
Raffles PharmaTech doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Raffles PharmaTech shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Raffles PharmaTech in its N-PORT filings yet. We sweep new filings monthly.